Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    AstraZeneca stock: time to sell?

    | Pam Narang

    Looking beyond the company’s vaccine woes, is now the time to make the most of the uptick in AstraZeneca stock…

    Read more »

    Investing Articles

    The AstraZeneca share price is rising fast. Here’s what I’d do now

    | Manika Premsingh

    The AstraZeneca share price is rising fast after its robust results. But can it rise much further from its already…

    Read more »

    Windmills for electric power production.
    Investing Articles

    ESG investing: which UK companies might I invest in?

    | Andy Ross

    A look at ESG investing and two UK FTSE 100 companies with strong ESG credentials, which might make them appealing…

    Read more »

    Investing Articles

    Novacyt or AstraZeneca: which biotech stock should I buy?

    | Kirsteen Mackay

    Novacyt and AstraZeneca are two biotech stocks working in the realms of fighting the Covid-19 pandemic. Are either good long-term…

    Read more »

    Scientist filling a needle
    Investing Articles

    3 reasons to buy the FTSE 100’s AstraZeneca stock now

    | Kevin Godbold

    Here's why I'd be keen to get a solid-looking business such as AstraZeneca into my long-term diversified portfolio right now.

    Read more »

    Syringe and vial on blue background
    Investing Articles

    Is the AstraZeneca share price undervalued?

    | Roland Head

    The AstraZeneca share price has been falling since last summer. Roland Head is starting to see a potential buying opportunity.

    Read more »

    Syringe and vial on blue background
    Investing Articles

    As the AstraZeneca share price slides, I’d buy

    | Rupert Hargreaves

    The AstraZeneca share price has been under pressure due to temporary headwinds, but these will not last forever and growth…

    Read more »

    Investing Articles

    2 unloved FTSE 100 stocks I’d buy before it’s too late

    | Ben Hargreaves

    With the FTSE 100 rising recently, one Fool looks at two companies that have been left behind and why this…

    Read more »

    Investing Articles

    These are 2 of my top stocks to buy in April 

    | Manika Premsingh

    These are Manika Premsingh's two top stocks because of their strong credentials combined with their current subdued share prices.

    Read more »

    Investing Articles

    Best stocks to buy: my money’s on AstraZeneca shares

    | Rupert Hargreaves

    In my basket of the best stocks to buy now, AstraZeneca shares feature prominently, considering the company's long-term outlook.

    Read more »

    Syringe and vial on blue background
    Investing Articles

    The AstraZeneca share price steadies: is this FTSE 100 stock a good investment?

    | Kirsteen Mackay

    The AstraZeneca share price is showing resilience in the face of disappointing vaccine publicity. This FTSE 100 stock has a…

    Read more »

    positive mental health woman
    Investing Articles

    2 FTSE 100 shares to buy right now

    | Rupert Hargreaves

    Rupert Hargreaves takes a look at a couple of his favourite FTSE 100 stocks he believes could be among the…

    Read more »